The FDA (Food and Drug Administration) recently issued a new safety alert for ‘high dose statin’ drugs prescribed by Doctors to lower cholesterol in patients at risk for heart disease. The FDA named the prescription drugs Crestor (rosuvastatin), Lipitor (atorvastatin), Zocor (simvastatin), and Pravachol (pravastatin), as well as the combination drug Vytorin (zetia/simvastatin) in the safety alert. The warning stated that the use of these drugs in high doses may be linked to memory loss, diabetes, and muscle pain. This was a general statement derived from a recent review of many different studies that were all part of the Women’s Health Initiative. The conclusions made from the analysis of these.